Schedule 6, Block Admission Period to 15 April 2021
This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the Company's block listing for employee share plans.
|
Name of the company |
Craneware plc (the "Company") |
|
|
|
|
Names of the schemes |
Approved Share Option Plan 2007
Schedule 4 Company Share Option Plan 2016
Unapproved Company Share Option Plan 2016
Long Term Incentive Plan 2016 |
|
|
|
|
Period of return: |
16/10/2020 to 15/04/2021 |
|
|
|
|
Balance of unallotted securities under scheme(s) from previous return: |
Approved Share Option Plan 2007: 342,301 Ordinary Shares
Schedule 4 Company Share Option Plan 2016: 50,000 Ordinary Shares
Unapproved Company Share Option Plan 2016: 200,000 Ordinary Shares
Long Term Incentive Plan 2016: 100,000 Ordinary Shares |
|
|
|
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
None |
|
|
|
|
Less: Number of securities issued/allotted under scheme(s) during period: |
None |
|
|
|
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
Approved Share Option Plan 2007: 342,301 Ordinary Shares
Schedule 4 Company Share Option Plan 2016: 50,000 Ordinary Shares
Unapproved Company Share Option Plan 2016: 200,000 Ordinary Shares
Long Term Incentive Plan 2016: 100,000 Ordinary Shares |
|
|
|
|
Number and class of securities originally admitted at the date of admission: |
24,929,950 Ordinary Shares on 13 September 2007 |
|
|
|
|
Contact name and telephone number:
|
Craig Preston +44 (0) 131 550 3100 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
